A new study published in HSR, an official journal of AcademyHealth, found that while the use of new cancer therapies did result in noteworthy improvements in lung cancer survival rates, Medicare spending increased substantially, raising concerns about the financial burden of these treatments.
In a recent webinar in collaboration with the National Pharmaceutical Council, experts discussed how to evaluate SDOH programs and interventions from a cost perspective. Speakers emphasized the incomplete state of current knowledge and the need to improve studies and data infrastructure to determine their value.
This webinar was part of series which seeks to promote serious evidence-based discussions related to costs, value, and allocation of health care spending.
Reflecting upon the 2019 Summit, “Imagining a World Without Low-Value Care: What Will it Take?” sponsored by AcademyHealth, the Donaghue Foundation, and the ABIM Foundation, in collaboration with the Kaiser Permanente Center for Total Health and the Veterans Administration, a commentary published in the American Journal of Managed Care explores the main barriers preventing progress against low-value care and highlights promising solutions.
In October 2019, researchers, policy experts, practicing physicians, funders, and other key stakeholders gathered for a summit to develop recommendations for reducing low-value care.
Lessons from the Field: Building Organizational Resiliency to Deliver High-Value Care in the Time of COVID
In a recent webinar for the Research Community on Low-Value Care, experts shared what their organizations have learned about building organizational resilience, recovery, and capacity during COVID-19. Speakers emphasized the need to re-design our health systems around high-value care, equity, and more stable payment structures.
As partners in the Going Below The Surface Forum, AcademyHealth and the National Pharmaceutical Council (NPC) consider the drivers of health spending in the United States through salons focused on challenging questions – which may not have immediate or universally accepted answers – as we attempt to push the conversation beyond the usual stakeholder posturing.
Medical care providers recognize the importance of discussing cost of care issues with their patients but have struggled to incorporate these conversations into clinical practice. This second of two posts focuses on integrating cost of care discussions into the clinical flow.
This is the first of a two-part series focused on the importance of screening for and addressing cost of care issues for patients and caregivers. It addresses both the obstacles and opportunities for incorporating cost of care discussions into clinical practice.
Summarizing an expert discussion at an August 2020 virtual meeting, this brief examines the COVID-19 vaccine development experience and reviews existing research on vaccine development, manufacturing, and distribution, including financing mechanisms to help ensure its accessibility, as well as policies to promote equity.